Pittsburgh Compound-B and Alzheimer’s Disease Biomarkers in CSF, Plasma and Urine: An Exploratory Study

Publisher： Karger

E-ISSN： 1421-9824|29|3|204-212

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.29, Iss.3, 2010-03, pp. : 204-212

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Study on the Association between SOAT1 Polymorphisms, Alzheimer’s Disease Risk and the Level of CSF Biomarkers

By  

Dementia and Geriatric Cognitive Disorders, Vol. 24, Iss. 2, 2007-07 ,pp. : 146-150

Karger

Access to resources Recommend Favorite

An Exploratory Study on Facial Emotion Recognition Capacity in Beginning Alzheimer’s Disease

By  

European Neurology, Vol. 65, Iss. 6, 2011-05 ,pp. : 361-367

Karger

Access to resources Recommend Favorite

CSF Biomarkers for Alzheimer’s Disease: Levels of β-Amyloid, Tau, Phosphorylated Tau Relate to Clinical Symptoms and Survival

By  

Dementia and Geriatric Cognitive Disorders, Vol. 21, Iss. 3, 2006-02 ,pp. : 131-138

Karger

Access to resources Recommend Favorite

Relation between Plasma Homocysteine and Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 14, Iss. 1, 2002-06 ,pp. : 7-12

Karger

Access to resources Recommend Favorite

Elevated Plasma Endothelial Microparticles in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 34, Iss. 3-4, 2012-10 ,pp. : 174-180

Karger

Access to resources Recommend Favorite